U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Congenital fibrosis of extraocular muscles type 1(CFEOM1)

MedGen UID:
376943
Concept ID:
C1851102
Disease or Syndrome
Synonyms: BLEPHAROPTOSIS WITH ABSENT EYE MOVEMENTS; Congenital Fibrosis of the Extraocular Muscles 1A; FEOM1 LOCUS; KIF21A-Related Congenital Fibrosis of the Extraocular Muscles; OPHTHALMOPLEGIA, CONGENITAL
 
Gene (location): KIF21A (12q12)
 
Monarch Initiative: MONDO:0021083
OMIM®: 135700

Definition

Congenital fibrosis of the extraocular muscles (CFEOM) encompasses several different inherited strabismus syndromes characterized by congenital restrictive ophthalmoplegia affecting extraocular muscles innervated by the oculomotor and/or trochlear nerves. Classic CFEOM is characterized by bilateral blepharoptosis and ophthalmoplegia with the eyes fixed in an infraducted position about 20 to 30 degrees below the horizontal midline. Involvement of the horizontal extraocular muscles is variable. If all affected members of a family have the classic phenotype with bilateral involvement, the disorder is referred to as 'CFEOM1' (Engle et al., 1997; Heidary et al., 2008). CFEOM2 (602078), an autosomal recessive disorder caused by mutation in the ARIX gene (PHOX2A; 602753) on chromosome 11q13, is characterized by bilateral ptosis with eyes fixed in an exotropic position. The CFEOM3 phenotype shows more variable clinical features: affected individuals may have unilateral eye involvement, may be able raise their eyes above midline, or may not have blepharoptosis. CFEOM3 is diagnosed in a family if even 1 member does not have classic findings of the disorder. CFEOM3 is a genetically heterogeneous disorder; CFEOM3A with or without extraocular involvement (600638) is caused by mutation in the TUBB3 gene (602661) on chromosome 16q24; CFEOM3B is caused by mutation in the KIF21A gene (608283) on chromosome 12q12; and CFEOM3C (609384) maps to chromosome 13q. CFEOM4 (609428), also known as Tukel syndrome, maps to chromosome 21q. CFEOM5 (616219) is caused by mutation in the COL25A1 gene (610004) on chromosome 4q25. See also NOMENCLATURE. [from OMIM]

Clinical features

From HPO
Congenital fibrosis of extraocular muscles
MedGen UID:
724506
Concept ID:
C1302995
Disease or Syndrome
Congenital fibrosis of the extraocular muscles (CFEOM) is a disorder of the nervous system that affects use of the muscles that surround the eyes (extraocular muscles). These muscles control eye movement and the direction of the eyes (for example, looking straight ahead). CFEOM impairs control of these muscles. As a result, affected individuals are unable to move their eyes normally. Most people with this condition have difficulty looking upward, and their side-to-side eye movement may also be limited. The eyes may look in different directions (strabismus). Instead of moving their eyes, affected individuals may need to turn their head to track moving objects. Additionally, most people with CFEOM have droopy eyelids (ptosis), which further limits their vision.\n\nResearchers have identified several forms of CFEOM, designated CFEOM1, CFEOM2, CFEOM3, and Tukel syndrome (sometimes called CFEOM4). The specific problems with eye movement vary among the types, and some types are associated with additional signs and symptoms. People with CFEOM1 and CFEOM2 have only the eye problems described above. In CFEOM1, the eyes typically point downward, whereas in CFEOM2, the eyes usually turn outward.\n\nCFEOM3 can include additional neurological problems, such as intellectual disability; difficulty with social skills; a smaller-than-normal head size (microcephaly); muscle weakness in the face; nonfunctioning vocal cords; and a set of symptoms called Kallmann syndrome, which features delayed or absent puberty and an impaired sense of smell. Some affected individuals develop pain, weakness, or a decreased ability to feel sensations in the limbs (peripheral neuropathy), which can begin in childhood or adulthood.\n\nBrain abnormalities can also occur in people with CFEOM3. Some have abnormal development of the white matter, which is brain tissue containing nerve cell fibers (axons) that transmit nerve impulses. A particular form of CFEOM3, known as CFEOM3 with polymicrogyria, is characterized by abnormal development of the brain, in which the folds and ridges on the surface of the brain are smaller and more numerous than usual.\n\nTukel syndrome is characterized by missing fingers (oligodactyly) and other hand abnormalities in addition to problems with eye movement.
Levator palpebrae superioris atrophy
MedGen UID:
342671
Concept ID:
C1851107
Finding
Atrophy of the levator palpebrae superioris, the extraocular muscle that elevates the superior eyelid.
Superior rectus atrophy
MedGen UID:
338207
Concept ID:
C1851108
Finding
Atrophy of the superior rectus, the extraocular muscle whose primary function is to elevate the globe.
Esotropia
MedGen UID:
4550
Concept ID:
C0014877
Disease or Syndrome
A form of strabismus with one or both eyes turned inward ('crossed') to a relatively severe degree, usually defined as 10 diopters or more.
Exotropia
MedGen UID:
4613
Concept ID:
C0015310
Disease or Syndrome
A form of strabismus with one or both eyes deviated outward.
Secondary esotropia
MedGen UID:
87391
Concept ID:
C0339624
Disease or Syndrome
Convergent squint which follows loss or impairment of vision.
Sensory exotropia
MedGen UID:
699219
Concept ID:
C1276000
Disease or Syndrome
A type of divergent strabismus (exotropia) that develops in a poorly seeing eye.
Compensatory chin elevation
MedGen UID:
337682
Concept ID:
C1846911
Finding
A tendency to hold the chin elevated by about 20 to 30 degrees to compensate for a limitation of eye movement.
Bilateral ptosis
MedGen UID:
356120
Concept ID:
C1865916
Disease or Syndrome
Restrictive external ophthalmoplegia
MedGen UID:
400877
Concept ID:
C1865918
Finding
Fibrosis of the external ocular muscles such that the eyes of affected individuals are partially or completely fixed in a strabismic position. Residual eye movements are significantly limited.

Professional guidelines

PubMed

Chen M, Huang R, Zhang Y, Zhu DJ, Shu Q, Xun P, Zhang J, Gu P, Li L
Graefes Arch Clin Exp Ophthalmol 2023 Mar;261(3):879-889. Epub 2022 Sep 23 doi: 10.1007/s00417-022-05830-3. PMID: 36138147Free PMC Article

Recent clinical studies

Etiology

Hedergott A, Pink-Theofylaktopoulos U, Neugebauer A, Fricke J
Graefes Arch Clin Exp Ophthalmol 2021 Jan;259(1):145-155. Epub 2020 Sep 19 doi: 10.1007/s00417-020-04939-7. PMID: 32949299Free PMC Article
Shoshany TN, Robson CD, Hunter DG
J AAPOS 2019 Dec;23(6):325.e1-325.e6. Epub 2019 Nov 2 doi: 10.1016/j.jaapos.2019.09.014. PMID: 31689500
MacKinnon S, Oystreck DT, Andrews C, Chan WM, Hunter DG, Engle EC
Ophthalmology 2014 Jul;121(7):1461-8. Epub 2014 Mar 6 doi: 10.1016/j.ophtha.2014.01.006. PMID: 24612975Free PMC Article
Lin LK, Chien YH, Wu JY, Wang AH, Chiang SC, Hwu WL
Mol Vis 2005 Apr 1;11:245-8. PMID: 15827546
Tiab L, d'Allèves Manzi V, Borruat FX, Munier F, Schorderet D
Ophthalmic Genet 2004 Dec;25(4):241-6. doi: 10.1080/13816810490902828. PMID: 15621876

Diagnosis

Chen M, Huang R, Zhang Y, Zhu DJ, Shu Q, Xun P, Zhang J, Gu P, Li L
Graefes Arch Clin Exp Ophthalmol 2023 Mar;261(3):879-889. Epub 2022 Sep 23 doi: 10.1007/s00417-022-05830-3. PMID: 36138147Free PMC Article
Shoshany TN, Robson CD, Hunter DG
J AAPOS 2019 Dec;23(6):325.e1-325.e6. Epub 2019 Nov 2 doi: 10.1016/j.jaapos.2019.09.014. PMID: 31689500
Oystreck DT
J Binocul Vis Ocul Motil 2018 Jan-Mar;68(1):31-33. Epub 2018 Jan 31 doi: 10.1080/2576117X.2017.1416242. PMID: 30196776
Allen RC
Curr Opin Ophthalmol 2013 Sep;24(5):463-77. doi: 10.1097/ICU.0b013e3283638219. PMID: 23846188
Lu S, Zhao C, Zhao K, Li N, Larsson C
Arch Ophthalmol 2008 Mar;126(3):388-94. doi: 10.1001/archopht.126.3.388. PMID: 18332320

Therapy

Cheng L, Desai J, Miranda CJ, Duncan JS, Qiu W, Nugent AA, Kolpak AL, Wu CC, Drokhlyansky E, Delisle MM, Chan WM, Wei Y, Propst F, Reck-Peterson SL, Fritzsch B, Engle EC
Neuron 2014 Apr 16;82(2):334-49. Epub 2014 Mar 20 doi: 10.1016/j.neuron.2014.02.038. PMID: 24656932Free PMC Article

Prognosis

Shoshany TN, Robson CD, Hunter DG
J AAPOS 2019 Dec;23(6):325.e1-325.e6. Epub 2019 Nov 2 doi: 10.1016/j.jaapos.2019.09.014. PMID: 31689500
Lu S, Zhao C, Zhao K, Li N, Larsson C
Arch Ophthalmol 2008 Mar;126(3):388-94. doi: 10.1001/archopht.126.3.388. PMID: 18332320
Miyake N, Tonoki H, Gallego M, Harada N, Shimokawa O, Yoshiura K, Ohta T, Kishino T, Niikawa N, Matsumoto N
J Hum Genet 2004;49(5):282-4. doi: 10.1007/s10038-004-0144-5. PMID: 15362574
Nakano M, Yamada K, Fain J, Sener EC, Selleck CJ, Awad AH, Zwaan J, Mullaney PB, Bosley TM, Engle EC
Nat Genet 2001 Nov;29(3):315-20. doi: 10.1038/ng744. PMID: 11600883

Clinical prediction guides

Chen J, Ye Q, Deng D, Yan J, Lin H, Shen T, Lin Y
Mol Med Rep 2016 Oct;14(4):3145-51. Epub 2016 Aug 11 doi: 10.3892/mmr.2016.5624. PMID: 27513105Free PMC Article
Wang P, Li S, Xiao X, Guo X, Zhang Q
Int J Mol Med 2011 Dec;28(6):973-5. Epub 2011 Jul 26 doi: 10.3892/ijmm.2011.759. PMID: 21805025
Zhang XQ, Peng JH, Tang ZH, Xu CQ, Zhou X, Gong SX, Liu JY, Wang Q, Liu MG
Yi Chuan Xue Bao 2006 Aug;33(8):685-91. doi: 10.1016/S0379-4172(06)60100-5. PMID: 16939002
Tiab L, d'Allèves Manzi V, Borruat FX, Munier F, Schorderet D
Ophthalmic Genet 2004 Dec;25(4):241-6. doi: 10.1080/13816810490902828. PMID: 15621876
Nakano M, Yamada K, Fain J, Sener EC, Selleck CJ, Awad AH, Zwaan J, Mullaney PB, Bosley TM, Engle EC
Nat Genet 2001 Nov;29(3):315-20. doi: 10.1038/ng744. PMID: 11600883

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...